Evaluation of KRAS mutation subtype on survival in patients with metastatic non-small cell lung cancer receiving immunotherapy

被引：0
|
作者：
Barron, C. C. [1 ]
Kuang, S. [1 ]
Makarem, M. [1 ]
Elliott, M. J. [1 ]
Sharma, K. [1 ]
Lee, J. [1 ]
Schmid, S. [1 ]
Rabinovitch, A. [1 ]
Bradbury, P. [1 ]
Liu, G. [1 ]
Shepherd, F. A. [1 ]
Tsao, M. S. [1 ]
Leighl, N. [1 ]
Rose, A. [2 ]
Pezo, R. [3 ]
Doherty, M. [4 ]
Cheng, S. [3 ]
Lau, S. C. [1 ]
Sacher, A. [1 ]
机构：
[1] Univ Hlth Network, Med Oncol, UHN, Princess Margaret Canc Ctr, Toronto, ON, Canada
[2] Jewish Gen Hosp, Segal Canc Ctr, Med Oncol, Montreal, PQ, Canada
[3] Odette Canc Ctr, Med Oncol, Toronto, ON, Canada
[4] Beaumont Hosp, Med Oncol, Dublin, Ireland
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.08.263
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1809P
引用
收藏
页码：S1229 / S1230
页数：2
相关论文
共 50 条
  • [1] Decoding KRAS mutation in non-small cell lung cancer patients receiving immunotherapy: A retrospective institutional comparison and literature review
    Urtecho, S. Berenice
    Provenzano, Leonardo
    Spagnoletti, Andrea
    Bottiglieri, Achille
    Pircher, Chiara
    Massa, Giacomo
    Sposetti, Caterina
    Proto, Claudia
    Brambilla, Marta
    Occhipinti, Mario
    Mazzeo, Laura
    Beninato, Teresa
    Leporati, Rita
    Giani, Claudia
    Cavalli, Chiara
    Serino, Roberta
    Prina, Marco Meazza
    Bassetti, Anna
    Nasca, Vincenzo
    di Mauro, Rosa Maria
    Abate, Alice
    Manglaviti, Sara
    Dumitrascu, Andra Diana
    Di Liberti, Giorgia
    Cassano, Teresa Serra
    Ganzinelli, Monica
    Wu, Sulin
    Garassino, Marina Chiara
    de Braud, Filippo G. M.
    Lo Russo, Giuseppe
    Prelaj, Arsela
    LUNG CANCER, 2025, 199
  • [2] Improving survival for patients with metastatic non-small cell lung cancer in the immunotherapy era
    Zhang, David
    Rohatgi, Anjali
    CANCER, 2025, 131 (01)
  • [3] Impact of KRAS mutation on non-small cell lung cancer survival outcomes
    Thomas, Q.
    Lemercier, P.
    Justeau, G.
    Schneider, S.
    Filleron, T.
    Masip, J. Remon
    Perol, M.
    Girard, N.
    Debieuvre, D.
    Valette, C. Audigier
    Chouaid, C.
    Loeb, A.
    Hiret, S.
    Clement-Duchene, C.
    Dansin, E.
    Stancu, A. T.
    Dubray-Longeras, P.
    Pichon, E.
    Bosquet, L.
    Quantin, X.
    ANNALS OF ONCOLOGY, 2023, 34
  • [4] Immunotherapy of metastatic non-small cell lung cancer
    Sackmann, Sandra
    Ogundele, Samuel
    Ukena, Dieter
    PNEUMOLOGE, 2019, 16 (06): : 353 - 365
  • [5] Radiotherapy for oligoprogression in metastatic non-small cell lung cancer patients receiving (chemo-)immunotherapy
    Deng, M.
    Bozorgmehr, F.
    Weykamp, F.
    Lang, K.
    Regnery, S.
    Held, T.
    Weusthof, K.
    Bauer, L.
    Waldsperger, H.
    Shafie, R. E.
    Rieken, S.
    Christopoulos, P.
    Thomas, M.
    Debus, J. Peter
    Adeberg, S.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2022, 198 (SUPPL 1) : S105 - S105
  • [6] Association of azole antifungals with survival in patients with non-small cell lung cancer receiving immunotherapy.
    Sebastian, Nikhil
    Stokes, William A.
    Behera, Madhusmita
    Jiang, Renjian
    Gutman, David
    Giuste, Felipe
    Burns, Abigail
    Ramalingam, Selvi
    Sukhatme, Vidula
    Lowe, Michael C.
    Ramalingam, Suresh S.
    Sukhatme, Vikas
    Moghanaki, Drew
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [7] Met activation sustains a metastatic phenotype in non-small cell lung cancer patients and is associated with KRAS mutation
    Benedettini, Elisa
    Vena, Natalie
    Bailey, Dyane
    Fiorentino, Michelangelo
    Fornari, Alessandro
    Bosari, Silvano
    Chirieac, Lucian
    Lutterbach, Bart
    Loda, Massimo
    CANCER RESEARCH, 2009, 69
  • [8] Impact of KRAS mutation subtype and concurrent pathogenic mutations on non-small cell lung cancer outcomes
    Aredo, Jacqueline, V
    Padda, Sukhmani K.
    Kunder, Christian A.
    Han, Summer S.
    Neal, Joel W.
    Shrager, Joseph B.
    Wakelee, Heather A.
    LUNG CANCER, 2019, 133 : 144 - 150
  • [9] Differential Diagnosis of Pneumonitis in Metastatic NSCLC (Non-Small Cell Lung Cancer) Patients Receiving Immunotherapy With Radiomics
    Traverso, A.
    Tohidinezhad, F.
    Bontempi, D.
    Dekker, A.
    Hendriks, L.
    De Ruysscher, D.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S118 - S119
  • [10] Lymphocyte changes in peripheral blood of metastatic non-small cell lung cancer patients receiving cryotherapy and immunotherapy
    Vasiliauskas, Gediminas
    Sabeckyte, Evelina
    Skrodeniene, Erika
    Poskiene, Lina
    Zemaitis, Marius
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
12345